Seminars in Fetal & Neonatal Medicine
Volume 13, Issue 2 , Pages 91-98 , April 2008

Post-genomics studies and their application to non-invasive prenatal diagnosis

  • Neil D. Avent

      Affiliations

    • Centre for Research in Biomedicine, Faculty of Health and Life Sciences, University of the West of England, Frenchay Campus, Coldharbour Lane, Bristol BS16 1QY, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 (0) 117 32 82147; fax: +44 (0) 117 32 82904.
    • ,
  • Zoe E. Plummer

      Affiliations

    • Centre for Research in Biomedicine, Faculty of Health and Life Sciences, University of the West of England, Frenchay Campus, Coldharbour Lane, Bristol BS16 1QY, UK
    • ,
  • Tracey E. Madgett

      Affiliations

    • Centre for Research in Biomedicine, Faculty of Health and Life Sciences, University of the West of England, Frenchay Campus, Coldharbour Lane, Bristol BS16 1QY, UK
    • ,
  • Deborah G. Maddocks

      Affiliations

    • Centre for Research in Biomedicine, Faculty of Health and Life Sciences, University of the West of England, Frenchay Campus, Coldharbour Lane, Bristol BS16 1QY, UK
    • ,
  • Peter W. Soothill

      Affiliations

    • St. Michael's Hospital, Southwell Street, Bristol, UK

References 

  1. Lapaire O, Holzgreve W, Oosterwijk JC, Brinkhaus R, Bianchi DW. Georg Schmorl on trophoblasts in the maternal circulation. Placenta. 2007;28(1):1–5
  2. Covone AE, Mutton D, Johnson PM, Adinolfi M. Trophoblast cells in peripheral blood from pregnant women. Lancet. 1984;2(8407):841–843
  3. Mathai M. Pre-eclampsia. Ceylon Med J. 1996;41(1):7–9
  4. Bertero MT, Camaschella C, Serra A, Bergui L, Caligaris-Cappio F. Circulating ‘trophoblast’ cells in pregnancy have maternal genetic markers. Prenat Diagn. 1988;8(8):585–590
  5. Covone AE, Kozma R, Johnson PM, Latt SA, Adinolfi M. Analysis of peripheral maternal blood samples for the presence of placenta-derived cells using Y-specific probes and McAb H315. Prenat Diagn. 1988;8(8):591–607
  6. Wapner RJ. Invasive prenatal diagnostic techniques. Semin Perinatol. 2005;29(6):401–404
  7. Walknowska J, Conte FA, Grumbach MM. Practical and theoretical implications of fetal–maternal lymphocyte transfer. Lancet. 1969;1(7606):1119–1122
  8. Herzenberg LA, Bianchi DW, Schroder J, Cann HM, Iverson GM. Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proc Natl Acad Sci U S A. 1979;76(3):1453–1455
  9. Iverson GM, Bianchi DW, Cann HM, Herzenberg LA. Detection and isolation of fetal cells from maternal blood using the fluorescence-activated cell sorter (FACS). Prenat Diagn. 1981;1(1):61–73
  10. Schroder J, Tiilikainen A, De la Chapelle A. Fetal leukocytes in the maternal circulation after delivery. I. Cytological aspects. Transplantation. 1974;17(4):346–354
  11. Tiilikainen A, Schroder J, De la Chapelle A. Fetal leukocytes in the maternal circulation after delivery. II. Masking of HL-A antigens. Transplantation. 1974;17(4):355–360
  12. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A. 1996;93(2):705–708
  13. Kleihauer E, Braun H, Betke K. Demonstration of fetal hemoglobin in erythrocytes of a blood smear, Klin Wochenschr. 1957;35(12):637–638
  14. Busch J, Huber P, Holtz J, Pfluger E, Radbruch A. Simple and fast ‘double-MACS’ sorting of fetal erythroblasts from maternal blood for PCR-based paternity analysis. Ann N Y Acad Sci. 1994;731:144–146
  15. Mavrou A, Colialexi A, Tsangaris GT, et al. Fetal cells in maternal blood: isolation by magnetic cell sorting and confirmation by immunophenotyping and FISH. In Vivo. 1998;12(2):195–200
  16. Bianchi DW, Flint AF, Pizzimenti MF, Knoll JH, Latt SA. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci U S A. 1990;87(9):3279–3283
  17. Savion S, Carp H, Shepshelovich J, et al. Use of antibodies against the human antigen of erythroblasts for the detection of nucleated erythrocytes in the maternal circulation. Biol Neonat. 1997;71(2):126–130
  18. Troeger C, Zhong XY, Burgemeister R, et al. Approximately half of the erythroblasts in maternal blood are of fetal origin. Mol Hum Reprod. 1999;5(12):1162–1165
  19. Hengstschlager M, Bernaschek G. Fetal cells in the peripheral blood of pregnant women express thymidine kinase: a new marker for detection. FEBS Lett. 1997;404(2–3):299–302
  20. Hennerbichler S, Kroisel PM, Zierler H, et al. Fetal nucleated red blood cells in peripheral blood of pregnant women: detection and determination of location on a slide using laser-scanning cytometry. Prenat Diagn. 2003;23(9):710–715
  21. Ho SS, O'Donoghue K, Choolani M. Fetal cells in maternal blood: state of the art for non-invasive prenatal diagnosis. Ann Acad Med Singap. 2003;32(5):597–603[quiz 604]
  22. Choolani M, O'Donoghue K, Talbert D, et al. Characterization of first trimester fetal erythroblasts for non-invasive prenatal diagnosis. Mol Hum Reprod. 2003;9(4):227–235
  23. Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics. 2004;4(12):3665–3685
  24. Low TY, Seow TK, Chung MC. Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics. 2002;2(9):1229–1239
  25. Kakhniashvili DG, Griko NB, Bulla LA, Goodman SR. The proteomics of sickle cell disease: profiling of erythrocyte membrane proteins by 2D-DIGE and tandem mass spectrometry. Exp Biol Med (Maywood). 2005;230(11):787–792
  26. Zimmermann B, El-Sheikhah A, Nicolaides K, Holzgreve W, Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem. 2005;51(9):1598–1604
  27. Dhallan R, Au WC, Mattagajasingh S, et al. Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA. 2004;291(9):1114–1119
  28. Dhallan R, Guo X, Emche S, et al. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet. 2007;369(9560):474–481
  29. Avent ND. Antenatal genotyping of the blood groups of the fetus. Vox Sang. 1998;74(Suppl. 2):365–374
  30. Hamlington J, Cunningham J, Mason G, Mueller R, Miller D. Prenatal detection of rhesus D genotype. Lancet. 1997;349(9051):540
  31. Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem. 2000;46(11):1832–1834
  32. Ng EK, Tsui NB, Lam NY, et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem. 2002;48(8):1212–1217
  33. Tsui NB, Ng EK, Lo YM. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem. 2002;48(10):1647–1653
  34. Ng EK, Tsui NB, Lau TK, et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A. 2003;100(8):4748–4753
  35. Chiu RW, Lui WB, Cheung MC, et al. Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma. Clin Chem. 2006;52(2):313–316
  36. Ng EK, Leung TN, Tsui NB, et al. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem. 2003;49(5):727–731
  37. Go AT, Visser A, Mulders MA, Blankenstein MA, Van Vugt JM, Oudejans CB. Detection of placental transcription factor mRNA in maternal plasma. Clin Chem. 2004;50(8):1413–1414
  38. Oudejans CB, Go AT, Visser A, et al. Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma. Clin Chem. 2003;49(9):1445–1449
  39. Go AT, Visser A, Mulders MA, et al. C21ORF105, a chromosome 21-encoded mRNA, is not a discriminative marker gene for prediction of Down syndrome in maternal plasma. Prenat Diagn. 2007;27(2):146–149
  40. Lo YM, Tsui NB, Chiu RW, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med. 2007;13(2):218–223
  41. Gross SJ, Ferreira JC, Morrow B, et al. Gene expression profile of trisomy 21 placentae: a potential approach for designing noninvasive techniques of prenatal diagnosis. Am J Obstet Gynecol. 2002;187(2):457–462
  42. Sood R, Zehnder JL, Druzin ML, Brown PO. Gene expression patterns in human placenta. Proc Natl Acad Sci U S A. 2006;103(14):5478–5483
  43. Rozovski U, Jonish-Grossman A, Bar-Shira A, Ochshorn Y, Goldstein M, Yaron Y. Genome-wide expression analysis of cultured trophoblast with trisomy 21 karyotype. Hum Reprod. 2007;22(9):2538–2545
  44. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol. 1984;148(7):886–894
  45. Wald NJ, Kennard A, Hackshaw A, McGuire A. Antenatal screening for Down's syndrome. J Med Screen. 1997;4(4):181–246
  46. Reddy UM, Mennuti MT. Incorporating first-trimester Down syndrome studies into prenatal screening: executive summary of the National Institute of Child Health and Human Development workshop. Obstet Gynecol. 2006;107(1):167–173
  47. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1(11):845–867
  48. Bahtiyar MO, Copel JA, Mahoney MJ, Buhimschi IA, Buhimschi CS. Proteomics: a novel methodology to complement prenatal diagnosis of chromosomal abnormalities and inherited human diseases. Am J Perinatol. 2007;24(3):167–181
  49. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis. 1997;18(11):2071–2077
  50. Tsangaris GT, Karamessinis P, Kolialexi A, et al. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics. 2006;6(15):4410–4419
  51. Michel PE, Crettaz D, Morier P, et al. Proteome analysis of human plasma and amniotic fluid by Off-Gel isoelectric focusing followed by nano-LC–MS/MS. Electrophoresis. 2006;27(5–6):1169–1181
  52. Nagalla SR, Canick JA, Jacob T, et al. Proteomic analysis of maternal serum in Down syndrome: identification of novel protein biomarkers. J Proteome Res. 2007;6(4):1245–1257
  53. Patterson SD, Aebersold R. Mass spectrometric approaches for the identification of gel-separated proteins. Electrophoresis. 1995;16(10):1791–1814
  54. Wang TH, Chang YL, Peng HH, et al. Rapid detection of fetal aneuploidy using proteomics approaches on amniotic fluid supernatant. Prenat Diagn. 2005;25:559–566
  55. Kuwata H, Yip TT, Yip CL, Tomita M, Hutchens TW. Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem Biophys Res Commun. 1998;245(3):764–773
  56. Busch A, Michel S, Hoppe C, Driesch D, Claussen U, von Eggeling F. Proteome analysis of maternal serum samples for trisomy 21 pregnancies using ProteinChip arrays and bioinformatics. J Histochem Cytochem. 2005;53(3):341–343
  57. Page NM, Kemp CF, Butlin DJ, Lowry PJ. Placental peptides as markers of gestational disease. Reproduction. 2002;123(4):487–495

PII: S1744-165X(07)00157-6

doi: 10.1016/j.siny.2007.12.011

Seminars in Fetal & Neonatal Medicine
Volume 13, Issue 2 , Pages 91-98 , April 2008

Article Tools

* Image Usage & Resolution